Matthew Ronsheim - Jan 18, 2022 Form 4 Insider Report for Entasis Therapeutics Holdings Inc. (ETTX)

Role
Chief of Pharmaceutical Sciences and Manufacturing
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Matthew Ronsheim
Stock symbol
ETTX
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 03:04 PM
Previous filing
Nov 3, 2021
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETTX Common Stock Award $0 +125K +293.62% $0.00 168K Jan 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests over four years with twenty-five percent of the award vesting on each anniversary of the date of grant, subject to the reporting person's continued employment with the Company.

Remarks:

Chief of Pharmaceutical Sciences and Manufacturing